- Previous Close
689.40 - Open
680.05 - Bid 631.65 x --
- Ask 637.60 x --
- Day's Range
626.70 - 686.50 - 52 Week Range
500.50 - 873.60 - Volume
4,676 - Avg. Volume
7,127 - Market Cap (intraday)
9.931B - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
61.33 - EPS (TTM)
10.28 - Earnings Date May 27, 2025 - May 31, 2025
- Forward Dividend & Yield 0.50 (0.08%)
- Ex-Dividend Date Sep 20, 2024
- 1y Target Est
--
Shivalik Rasayan Limited produces and sells chemicals for the protection of plants in India. The company offers Dimethoate technical, which is used in the preparation of formulations for use in the control of various insects and mites; and Malathion technical, an organophosphorus based contact insecticide used in the agricultural production of various food/feed crops. It also manufactures organophosphorus-based insecticides and chemicals. In addition, it develops and manufactures active pharmaceutical ingredients in oncology, ARVs, cardiovascular, metabolic disorders, and immunology; and manufactures oncology and non-oncology products. Further, the company offers custom manufacturing of chemicals. Shivalik Rasayan Limited was incorporated in 1979 and is based in New Delhi, India. ]
www.shivalikrasayan.com267
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: SHIVALIK.BO
View MorePerformance Overview: SHIVALIK.BO
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHIVALIK.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHIVALIK.BO
View MoreValuation Measures
Market Cap
9.93B
Enterprise Value
10.53B
Trailing P/E
61.27
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.18
Price/Book (mrq)
1.96
Enterprise Value/Revenue
3.37
Enterprise Value/EBITDA
21.95
Financial Highlights
Profitability and Income Statement
Profit Margin
5.18%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.12B
Net Income Avi to Common (ttm)
161.55M
Diluted EPS (ttm)
10.28
Balance Sheet and Cash Flow
Total Cash (mrq)
369.72M
Total Debt/Equity (mrq)
19.06%
Levered Free Cash Flow (ttm)
--